Compartment Syndrome Clinical Trial
Official title:
Continuous Compartment Pressure Monitoring (Ccpm) Following Tibial Fracture: A Prospective Randomized Trial
Verified date | March 2010 |
Source | University of British Columbia |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Health Canada |
Study type | Interventional |
This study has been designed to allow us to learn more about diagnosing Compartment Syndrome, which is a condition that occurs in approximately 5% of tibial (lower leg) fractures. In Compartment Syndrome, nerves, muscle and blood vessels are affected by swelling within the enclosed spaces (compartments) of the leg. The tissue covering these compartments (called the fascia) is not expandable and is not able to accommodate this swelling, and so the tissues within the compartments become compressed. If the pressure is not relieved it can result in blood flow being blocked to the inside of the compartment (muscle, blood vessels, and nerves) which can lead to permanent injury to the muscle and nerves. Late complications in untreated compartment syndrome include a failure of the injured bone to heal, nerve damage, and contracture (shortening) of muscle, all of which can result in a weak, painful, stiff, and poorly formed limb that is not functioning well, and could result in amputation.
Status | Terminated |
Enrollment | 250 |
Est. completion date | March 2010 |
Est. primary completion date | March 2010 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 16 Years and older |
Eligibility |
Inclusion Criteria: - 16 years of age and older, presenting for treatment in 24 hours or less - Diaphyseal or bicondylar plateau fracture of the tibia Exclusion Criteria: - Patients under 16 years of age - Patients who present to VGH more than 24 hours after the injury - Patients who are not mentally competent to give Informed Consent |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Country | Name | City | State |
---|---|---|---|
Canada | Vancouver General Hospital | Vancouver | British Columbia |
Lead Sponsor | Collaborator |
---|---|
University of British Columbia |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Outcome measures will be assessed at the time of discharge and at the six and twelve month clinical appointments and will be as follows: | Unspecified | No | |
Primary | Fasciotomy rate | Unspecified | No | |
Secondary | Outcome measures will be assessed at the time of discharge and at the six and twelve month clinical appointments and will be as follows:Time from injury to fasciotomy 2) Early local outcomes 3) Late local outcomes | Unspecified | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00921271 -
The Application of Near Infrared Spectroscopy (NIRS) in the Detection of Lower Limb Compartment Syndrome
|
N/A | |
Completed |
NCT01077934 -
Assessment of Near Infrared Spectroscopy as a Diagnostic Tool in Acute Compartment Syndrome
|
N/A | |
Not yet recruiting |
NCT01879696 -
Double Blinded, Randomized Clinical Trial of the Twin Star ECSPRESS Monitoring System for the Reduction of the Incidence of Fasciotomy
|
N/A | |
Completed |
NCT00022815 -
Management of Compartment Syndrome With Ultrafiltration
|
Phase 1 | |
Completed |
NCT03840434 -
COmpartment Syndrome vaLidation Of Non Invasive Assessment of Tissue Pressure
|
N/A | |
Terminated |
NCT01171534 -
Closure of Fasciotomy Wounds: A Prospective, Observational Study of a Continuous External Tissue Expander
|
N/A | |
Completed |
NCT01837264 -
Phase I, Arteriocyte Magellan MAR01 Therapy - Compartment Syndrome and Battlefield Trauma
|
Phase 1 | |
Recruiting |
NCT00681616 -
Study of New Catheter & Pressure Monitor System to Help Prevent Compartment Syndrome From Developing in the Injured Leg
|
N/A | |
Recruiting |
NCT02683252 -
Musculoskeletal Non-tumoral Pathology Quantitative Perfusion
|
N/A |